Mitochondrial genetic variation and risk of chronic kidney disease and acute kidney injury in UK Biobank participants

Experimental models suggest an important role for mitochondrial dysfunction in the pathogenesis of chronic kidney disease (CKD) and acute kidney injury (AKI), but little is known regarding the impact of common mitochondrial genetic variation on kidney health. We sought to evaluate associations of inherited mitochondrial DNA (mtDNA) variation with risk of CKD and AKI in a large population-based cohort. We categorized UK Biobank participants who self-identified as white into eight distinct mtDNA haplotypes, which were previously identified based on their associations with phenotypes associated with mitochondrial DNA copy number, a measure of mitochondrial function. We used linear and logistic regression models to evaluate associations of these mtDNA haplotypes with estimated glomerular filtration rate by serum creatinine and cystatin C (eGFR Cr-CysC , N = 362,802), prevalent ( N = 416 cases) and incident ( N = 405 cases) end-stage kidney disease (ESKD), AKI defined by diagnostic codes ( N = 14,170 cases), and urine albumin/creatinine ratio (ACR, N = 114,662). The mean age was 57 ± 8 years and the mean eGFR was 90 ± 14 ml/min/1.73 m 2 . MtDNA haplotype was significantly associated with eGFR ( p = 2.8E−12), but not with prevalent ESKD ( p = 5.9E−2), incident ESKD ( p = 0.93), AKI ( p = 0.26), or urine ACR ( p = 0.54). The association of mtDNA haplotype with eGFR remained significant after adjustment for diabetes mellitus and hypertension ( p = 1.2E−10). When compared to the reference haplotype, mtDNA haplotypes I ( β = 0.402, standard error (SE) = 0.111; p = 2.7E−4), IV ( β = 0.430, SE = 0.073; p = 4.2E−9), and V ( β = 0.233, SE = 0.050; p = 2.7E−6) were each associated with higher eGFR. Among self-identified white UK Biobank participants, mtDNA haplotype was associated with eGFR, but not with ESKD, AKI or albuminuria.